Oxidative stress is associated with adiposity and insulin resistance in men

被引:330
作者
Urakawa, H
Katsuki, A
Sumida, Y
Gabazza, EC
Murashima, S
Morioka, K
Maruyama, N
Kitagawa, N
Tanaka, T
Hori, Y
Nakatani, K
Yano, Y
Adachi, Y
机构
[1] Mie Univ, Sch Med, Dept Internal Med 3, Tsu, Mie 5148507, Japan
[2] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 5148507, Japan
[3] Mie Univ, Sch Med, Dept Lab Med, Tsu, Mie 5148507, Japan
关键词
D O I
10.1210/jc.2003-030202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the direct relationship of oxidative stress with obesity and insulin resistance in men, we measured the plasma levels of 8-epi-prostaglandin F2alpha (PGF2alpha) in 14 obese and 17 nonobese men and evaluated their relationship with body mass index; body fat weight; visceral, sc, and total fat areas, measured by computed tomography; and glucose infusion rate during a euglycemic hyperinsulinemic clamp study. Obese men had significantly higher plasma concentrations of 8-epi-PGF2alpha than nonobese men (P < 0.05). The plasma levels of 8-epi-PGF2 alpha were significantly correlated with body mass index (r = 0.408; P < 0.05), body fat weight (r = 0.467; P < 0.05), visceral (r = 0.387; P < 0.05) and total fat area (r = 0.359; P < 0.05) in all (obese and nonobese) men. There was also a significant correlation between the plasma levels of 8-epi-PGF2 alpha and glucose infusion rate in obese men (r = -0.552; P < 0.05) and all men (r = -0.668; P < 0.01). In all subjects, the plasma levels of 8-epi-PGF2 alpha were significantly correlated with fasting serum levels of insulin (r = 0.487; P < 0.01). In brief, these findings showed that the circulating levels of 8-epi-PGF2alpha are related to adiposity and insulin resistance in men. Although correlation does not prove causation, the results of this study suggest that obesity is an important factor for enhanced oxidative stress and that this oxidative stress triggers the development of insulin resistance in men.
引用
收藏
页码:4673 / 4676
页数:4
相关论文
共 37 条
[1]   Role of redox potential and reactive oxygen species in stress signaling [J].
Adler, V ;
Yin, ZM ;
Tew, KD ;
Ronai, Z .
ONCOGENE, 1999, 18 (45) :6104-6111
[2]   Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects:: Evidence for an anti-inflammatory effect? [J].
Dandona, P ;
Aljada, A ;
Mohanty, P ;
Ghanim, H ;
Hamouda, W ;
Assian, E ;
Ahmad, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3257-3265
[3]   Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations [J].
Dandona, P ;
Mohanty, P ;
Hamouda, W ;
Ghanim, H ;
Aljada, A ;
Garg, R ;
Kumar, V .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06) :2899-2902
[4]   The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation [J].
Dandona, P ;
Mohanty, P ;
Ghanim, H ;
Aljada, A ;
Browne, R ;
Hamouda, W ;
Prabhala, A ;
Afzal, A ;
Garg, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :355-362
[5]   Platelet activation in obese women -: Role of inflammation and oxidant stress [J].
Davì, G ;
Guagnano, MT ;
Ciabattoni, G ;
Basili, S ;
Falco, A ;
Marinopiccoli, M ;
Nutini, M ;
Sensi, S ;
Patrono, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2008-2014
[6]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[7]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, P214
[8]   Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? [J].
Evans, JL ;
Goldfine, ID ;
Maddux, BA ;
Grodsky, GM .
DIABETES, 2003, 52 (01) :1-8
[9]   Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes [J].
Evans, JL ;
Goldfine, ID ;
Maddux, BA ;
Grodsky, GM .
ENDOCRINE REVIEWS, 2002, 23 (05) :599-622
[10]  
Gavin JR, 1997, DIABETES CARE, V20, P1183